McLaughlin Matthew T E 4
4 · Oxford Immunotec Global PLC · Filed Mar 13, 2020
Insider Transaction Report
Form 4
McLaughlin Matthew T E
Chief Financial Officer
Transactions
- Award
Share Option (Right to Buy)
2020-03-11+34,795→ 34,795 totalExercise: $12.19Exp: 2030-03-11→ Ordinary Shares (34,795 underlying) - Award
Ordinary Shares
2020-03-11+34,795→ 61,407 total
Footnotes (2)
- [F1]Options granted under Issuer's 2013 Share Incentive Plan.
- [F2]Options will become exercisable ratably on the anniversary of the vesting start date from January 1, 2021 through January 1, 2024.